SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntellia Therapeutics Share Price (0JBU)

Share Price Information for Intellia Therapeutics (0JBU)

Share Price is delayed by 15 minutes
Get Live Data
12.10    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $1.72b
0JBU Live PriceLast checked at - London Stock Exchange

Intraday Intellia Therapeutics Share Chart

  • This share is an international stock.
Intellia Therapeutics Share Price
Price 12.10 Open 0.00
Bid 0.00 High 0.00
Ask 0.00 Low 0.00
Change 0.00 (0.00%) Close 12.29
Volume 45,102
Currency USD
Issue Country DE
Shares in Issue 139.72m
Market Cap $1.72b
PE Ratio -3.225722
EPS -3.81
Year High 27.23088
Year High Date 21-Oct-2025
Year Low 8.143672
Year Low Date 17-Jun-2025
Dividend 0.00
Yield 0.00%
# Trades 276
Vol. Sold 0
Sold Value $N/A
Vol. Bought 0
Bought Value $N/A
Market Size 0
What if I invested $1,000 in Intellia Therapeutics?
$ 900.97 (-9.90%)
1 month ago
$ 958.04 (-4.20%)
3 months ago
$ 1,278.45 (+27.84%)
6 months ago
$ 1,485.82 (+48.58%)
1 year ago
Add 0JBU to WatchlistAdd 0JBU to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Active Traders
View Offer
Capital at risk
Great for:
Copy Trading
View Offer
Other fees apply.
Capital at risk.
Great for:
ISAs & SIPPs
View Offer
Capital at risk
Great for:
Beginner Friendly
View Offer
Capital at risk
Intellia Therapeutics Inc Intellia Therapeutics Ord Shs

Intellia Therapeutics Inc Intellia Therapeutics Ord Shs is listed on the London Stock Exchange trading with ticker code 0JBU.L. It has a market capitalisation of $1.72b, with approximately 139.72m shares in issue. Over the last year, Intellia Therapeutics share price has been traded in a range of 19.0872, hitting a high of 27.23088, and a low of 8.143672.

Intellia Therapeutics plc is a leading biotechnology company headquartered in Cambridge, Massachusetts. Founded in 2014, the company focuses on developing innovative, gene-editing therapies using CRISPR/Cas9 technology. Intellia's research aims to treat severe and life-threatening diseases by targeting and modifying specific genetic defects. The company's pipeline includes potential treatments for conditions such as transthyretin amyloidosis, hereditary angioedema, and haemophilia. Committed to advancing the field of gene therapy, Intellia Therapeutics collaborates with academic institutions and industry partners to translate groundbreaking science into transformative treatments, improving patients' lives worldwide.

Recent Share Trades for Intellia Therapeutics (0JBU)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
12-Jun-2619:14:3812.100Unknown*0.000.000.00O Ordinary
Trade was executed as an SI
12-Jun-2619:12:4212.150Unknown*0.000.000.00O Ordinary
Trade was executed as an SI
12-Jun-2619:11:2612.1181,700Unknown*0.000.0020.60kO Ordinary
Was reported as OTC
12-Jun-2619:11:2612.115200Unknown*0.000.002,423O Ordinary
Was reported as OTC
12-Jun-2619:10:4112.111Unknown*0.000.0012.11O Ordinary
Was reported as OTC
12-Jun-2619:09:2312.0707300Unknown*0.000.003,621O Ordinary
Was reported as OTC
12-Jun-2615:47:5212.390Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
12-Jun-2619:05:2012.080Unknown*0.000.000.00O Ordinary
Trade was executed as an SI
12-Jun-2618:57:5212.100Unknown*0.000.000.00O Ordinary
Trade was executed as an SI
12-Jun-2618:55:5412.106Unknown*0.000.0072.60O Ordinary
Trade was executed as an SI

Directors Deals for Intellia Therapeutics (0JBU)

Announced Traded Action Notifier Price Currency Amount Holding
  • No Directors Deals found.
  • There are no chat posts for Intellia Therapeutics